Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This company develops human monoclonal antibody therapies to treat neuropathic pain by targeting and inactivating specific matrix metalloproteinases. Their approach offers an alternative to opioids by addressing the underlying causes of chronic pain.